GO
Loading...

Celgene Corp

More

  • Midday Glance: Biotechnology companies Thursday, 30 Oct 2014 | 1:17 PM ET

    Amgen Inc. rose $1.58 or 1.0 percent, to $160.46. Biogen Idec rose $7.39 or 2.3 percent, to $322.45. Celgene Corp. rose $1.80 or 1.7 percent, to $106.94.

  • Early Glance: Biotechnology companies Thursday, 30 Oct 2014 | 11:28 AM ET

    Amgen Inc. fell$. 40 or. 3 percent, to $158.48. Biogen Idec rose$. 43 or. 1 percent, to $315.49. Celgene Corp. fell$. 35 or. 3 percent, to $104.79.

  • Final Glance: Biotechnology companies Wednesday, 29 Oct 2014 | 6:02 PM ET

    Amgen Inc. rose $1.69 or 1.1 percent, to $158.88. Biogen Idec fell $2.97 or. 9 percent, to $315.06. Celgene Corp. fell$. 56 or. 5 percent, to $105.14.

  • Midday Glance: Biotechnology companies Wednesday, 29 Oct 2014 | 1:41 PM ET

    Amgen Inc. rose $1.86 or 1.2 percent, to $159.05. Biogen Idec fell $3.36 or 1.1 percent, to $314.67. Celgene Corp. fell$. 67 or. 6 percent, to $105.03.

  • Early Glance: Biotechnology companies Wednesday, 29 Oct 2014 | 10:53 AM ET

    Amgen Inc. rose$. 90 or. 6 percent, to $158.09. Biogen Idec rose $1.09 or. 3 percent, to $319.12. Celgene Corp. rose$. 43 or. 4 percent, to $106.13.

  • Final Glance: Biotechnology companies Tuesday, 28 Oct 2014 | 6:14 PM ET

    Amgen Inc. rose $8.99 or 6.1 percent, to $157.19. Biogen Idec fell $1.95 or. 6 percent, to $318.03. Celgene Corp. rose $2.60 or 2.5 percent, to $105.70.

  • Midday Glance: Biotechnology companies Tuesday, 28 Oct 2014 | 1:25 PM ET

    Amgen Inc. rose $7.24 or 4.9 percent, to $155.44. Biogen Idec fell $3.28 or 1.0 percent, to $316.70. Celgene Corp. rose $2.18 or 2.1 percent, to $105.28.

  • Early Glance: Biotechnology companies Tuesday, 28 Oct 2014 | 10:31 AM ET

    Amgen Inc. rose $6.60 or 4.5 percent, to $154.80. Biogen Idec fell $1.10 or. 3 percent, to $318.88. Celgene Corp. rose $2.18 or 2.1 percent, to $105.28.

  • Final Glance: Biotechnology companies Monday, 27 Oct 2014 | 6:06 PM ET

    Amgen Inc. rose$. 94 or. 6 percent, to $148.20. Biogen Idec fell $1.69 or. 5 percent, to $319.98. Celgene Corp. fell$. 14 or. 1 percent, to $103.10.

  • Oct 27- Amgen Inc on Monday reported higher-than-expected third quarter profit and revenue, helped by strong demand for its white blood cell booster, Neulasta, and increased sales of newer drugs, and the company raised its full-year forecast. Amgen shares are up almost 20 percent since the restructuring announcement that involved plant closings and the...

  • Midday Glance: Biotechnology companies Monday, 27 Oct 2014 | 1:17 PM ET

    Amgen Inc. rose$. 57 or. 4 percent, to $147.83. Biogen Idec fell $2.92 or. 9 percent, to $318.75. Celgene Corp. fell$. 19 or. 2 percent, to $103.05.

  • Early Glance: Biotechnology companies Monday, 27 Oct 2014 | 10:40 AM ET

    Amgen Inc. fell$. 07 or percent, to $147.19. Biogen Idec fell $3.44 or 1.1 percent, to $318.23. Celgene Corp. fell$. 47 or. 5 percent, to $102.77.

  • Final Glance: Biotechnology companies Friday, 24 Oct 2014 | 6:35 PM ET

    Amgen Inc. rose$. 01 or percent, to $147.26. Biogen Idec rose $5.61 or 1.8 percent, to $321.67. Celgene Corp. rose $2.84 or 2.8 percent, to $103.24.

  • Oct 24- Amgen Inc, one of the world's largest biotechnology companies, will unveil next week its first strategy update since early 2013, but few expect a major shift like the split-up recently proposed by Daniel Loeb's Third Point hedge fund. In a letter to investors on Tuesday, Loeb said Amgen has "all the hallmarks of a hidden value situation" and should divide...

  • Midday Glance: Biotechnology companies Friday, 24 Oct 2014 | 1:17 PM ET

    Amgen Inc. fell $1.41 or 1.0 percent, to $145.84. Biogen Idec rose $3.09 or 1.0 percent, to $319.15. Celgene Corp. rose $2.15 or 2.1 percent, to $102.55.

  • Early Glance: Biotechnology companies Friday, 24 Oct 2014 | 10:40 AM ET

    Amgen Inc. fell$. 43 or. 3 percent, to $146.82. Biogen Idec rose $1.58 or. 5 percent, to $317.64. Celgene Corp. rose $1.93 or 1.9 percent, to $102.33.

  • Final Glance: Biotechnology companies Thursday, 23 Oct 2014 | 6:02 PM ET

    Amgen Inc. rose $3.61 or 2.5 percent, to $147.25. Biogen Idec rose $6.99 or 2.3 percent, to $316.06. Celgene Corp. rose $5.64 or 6.0 percent, to $100.40.

  • Midday Glance: Biotechnology companies Thursday, 23 Oct 2014 | 1:51 PM ET

    Amgen Inc. rose $3.75 or 2.6 percent, to $147.39. Biogen Idec rose $7.67 or 2.5 percent, to $316.74. Celgene Corp. rose $5.82 or 6.1 percent, to $100.58.

  • Early Glance: Biotechnology companies Thursday, 23 Oct 2014 | 11:56 AM ET

    Amgen Inc. rose $3.58 or 2.5 percent, to $147.22. Biogen Idec rose $4.73 or 1.5 percent, to $313.80. Celgene Corp. rose $2.67 or 2.8 percent, to $97.43.

  • Celgene 3Q profit climbs; company lifts outlook Thursday, 23 Oct 2014 | 7:54 AM ET

    NEW YORK— Celgene Corp. said Thursday that its net income climbed 37 percent in the third quarter, and the biotechnology company raised its forecast for the full year. Celgene also announced a new cancer drug development partnership with a price tag that could top $1 billion. Excluding one-time items Celgene said it earned 97 cents per share.